Skip to content

A Comparative Study On Treatment Of Unknown bite By Two Group Of Siddha Medicines

A Comparative Pilot Study On Treatment Of Kanakadi By Two Groups Of Siddha Medicines-Gowri Chinthamani Chendooram With Thirikadugu Chooranam And Elathy Chooranam With Palagarai Parpam

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/018938
Enrollment
20
Registered
2019-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Gowrichinthamani Chendooram with Thirikadugu chooranam and Elathy chooranam with Palagarai parpam: Group I Medicine Gowrichinthamani chendooram(130 mg) and Thirikadugu chooranam (1 gm)w

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering from Urticaria, Willing to Give Blood and Urine Sample For Laboratory Investigation, Patients willing to attend the OPD, Patient willing to sign the informed consent stating that he/she will consciously stick to the treatment during 48 days and the patients can opt out of the trail of his/her own conscious discretion.

Exclusion criteria

Exclusion criteria: Pregnancy and Lactation Diabetes mellitus Hypertension Psychosomatic disorders Cardiac disease Hepatic disorders Any other serious systemic illness

Design outcomes

Primary

MeasureTime frame
Urticaria will be assessed by Universal Urticaria assessment scale and reduction of ESR level after treatment. Timepoint: 48 days

Secondary

MeasureTime frame
Effectiveness of Gowrichinthamani chendooram with thirikaduku chooranam (Group I Medicine) and Elathy Chooranam with Palagarai Parpam (Group II Medicine) in UrticariaTimepoint: 48 days

Countries

India

Contacts

Public ContactDr Sujitha M

National Institute of Siddha

ss.drss@gmail.com9841108269

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026